These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32368834)

  • 1. Exploratory descriptive analysis of opioid prescribing prevalence of nurse practitioners and the specialties associated with the top prescribers.
    Pan K; Collins A
    Int J Nurs Pract; 2020 Dec; 26(6):e12850. PubMed ID: 32368834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An examination of opioid prescription for Medicare Part D patients among family practice prescribers.
    Pan K; Blankley AI; Hughes PJ
    Fam Pract; 2019 Jul; 36(4):467-472. PubMed ID: 30239656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-prescribing Outcomes of Medicare Beneficiaries Managed by Nurse Practitioners and Physicians.
    Muench U; Spetz J; Jura M; Guo C; Thomas C; Perloff J
    Med Care; 2019 Jun; 57(6):482-489. PubMed ID: 31008896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population.
    Cao S; Karmouta R; Li DG; Din RS; Mostaghimi A
    JAMA Dermatol; 2018 Mar; 154(3):317-322. PubMed ID: 29417134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Opioid Prescribing Among Generalist Physicians, Nurse Practitioners, and Physician Assistants.
    Ellenbogen MI; Segal JB
    Pain Med; 2020 Jan; 21(1):76-83. PubMed ID: 30821817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying opioid prescribing patterns for high-volume prescribers via cluster analysis.
    Nataraj N; Zhang K; Guy GP; Losby JL
    Drug Alcohol Depend; 2019 Apr; 197():250-254. PubMed ID: 30875645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid prescription by gynecologic oncologists: An analysis of Medicare Part D claims.
    Samuel D; Nevadunsky NS; Miller DT; Isani S; Kuo DYS; Gressel GM
    Curr Probl Cancer; 2021 Apr; 45(2):100655. PubMed ID: 32994074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Prescribing by Nurse Practitioners in Medicare Part D: Impact of State Scope of Practice Legislation.
    Ladd E; Sweeney CF; Guarino A; Hoyt A
    Med Care Res Rev; 2019 Jun; 76(3):337-353. PubMed ID: 29148351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of prescriber risk indicators obtained from prescription drug monitoring program data.
    Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Opioid Use and Prescribing in Medicare, 2006-2012.
    Axeen S
    Health Serv Res; 2018 Oct; 53(5):3309-3328. PubMed ID: 29532477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.
    Chang HY; Murimi IB; Jones CM; Alexander GC
    Addiction; 2018 Apr; 113(4):677-686. PubMed ID: 29193546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Prescribing by Primary Care Providers: a Cross-Sectional Analysis of Nurse Practitioner, Physician Assistant, and Physician Prescribing Patterns.
    Lozada MJ; Raji MA; Goodwin JS; Kuo YF
    J Gen Intern Med; 2020 Sep; 35(9):2584-2592. PubMed ID: 32333312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
    Pan K; Silver S; Davis C
    Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
    Fink PB; Deyo RA; Hallvik SE; Hildebran C
    Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National opioid prescribing trends in emergency departments by provider type: 2005-2015.
    Yang BK; Storr CL; Trinkoff AM; Sohn M; Idzik SK; McKinnon M
    Am J Emerg Med; 2019 Aug; 37(8):1439-1445. PubMed ID: 30377010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Opioid Prescriptions by Mohs Surgeons in the Medicare Population.
    Feng H; Kakpovbia E; Petriceks AP; Feng PW; Geronemus RG
    Dermatol Surg; 2020 Mar; 46(3):335-340. PubMed ID: 31356436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical payments to physicians may increase prescribing for opioids.
    Nguyen TD; Bradford WD; Simon KI
    Addiction; 2019 Jun; 114(6):1051-1059. PubMed ID: 30667135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.